Prospective Study for Antitumoral Agents from the Sea Hare Aplysia dactylomela

vol. 1, 2019 - 117427
Poster
Favorite this paper
How to cite this paper?
Abstract

Studies with organisms from marine habitat have provided to be a rich source of secondary metabolites with therapeutic potential. Among marine organisms, invertebrates have been the mainstream source in marine‐derived drug discovery, contributing approximately to 65% of the marine natural products reported to date. Cytotoxic potential for tumor cell lines has been the most biological activity explored, contributing to the emergence of compounds as models for the development of new anticancer drugs such as didemnin B, frondoside A, eribulin, among others. Previous chemical investigations of the sea hare Aplysia dactylomela found worldwide in tropical to warm temperate waters reported the isolation of two principal groups of compounds, terpenes and nonterpenoid C-15 acetogenins exhibiting potential anticancer. Thus, the objective of the present study was to evaluate the antitumor property of extract and fractions of sea hare A. dactylomela collected on the coast of Espirito Santo State, Brazil, through a biomonitoring study in the search for active compounds. For the study, after the collection the sample was freeze-dried and the extract was prepared in non-polar solvents. Fractions were obtained through partition and chromatography and subjected to bioassay-guided isolation. One compound isolated by HPLC showed efficacy in human HCT116 cancer cells. Structure elucidation using NMR and MS is in process.

Institutions
  • 1 Department of Pharmaceutical Sciences/ Federal University of Espírito Santo
  • 2 Department of Oceanography and Ecology / Federal University Espírito Santo
  • 3 Department of Medicinal Chemistry / College of Pharmacy / University of Florida
Track
  • 2. Biological and Pharmacological Activity of Natural Products
Keywords
marine natural products; antitumoral; bioprospection